Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{53ce0676efdc44e0953976e767cb8983,

title = "Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?",

author = "Dunhui Li and Mastaglia, {Frank L.} and Yau, {Wai Yan} and Shengdi Chen and Wilton, {Steve D.} and Akkari, {Patrick A.}",

year = "2022",

month = nov,

doi = "10.1002/mds.29201",

language = "English",

volume = "37",

pages = "2184--2190",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley & Sons",

number = "11",

}

TY - JOUR

T1 - Targeted Molecular Therapeutics for Parkinson's Disease

T2 - A Role for Antisense Oligonucleotides?

AU - Li, Dunhui

AU - Mastaglia, Frank L.

AU - Yau, Wai Yan

AU - Chen, Shengdi

AU - Wilton, Steve D.

AU - Akkari, Patrick A.

PY - 2022/11

Y1 - 2022/11

U2 - 10.1002/mds.29201

DO - 10.1002/mds.29201

M3 - Article

C2 - 36036206

SN - 0885-3185

VL - 37

SP - 2184

EP - 2190

JO - Movement Disorders

JF - Movement Disorders

IS - 11

ER -